(Press-News.org) CAMBRIDGE, MA -- Over the past few decades, scientists have developed many devices that can reopen clogged arteries, including angioplasty balloons and metallic stents. While generally effective, each of these treatments has drawbacks, including the risk of side effects.
A new study from MIT analyzes the potential usefulness of a new treatment that combines the benefits of angioplasty balloons and drug-releasing stents, but may pose fewer risks. With this new approach, a balloon is inflated in the artery for only a brief period, during which it releases a drug that prevents cells from accumulating and clogging the arteries over time.
While approved for limited use in Europe, these drug-coated balloons are still in development in the United States and have not received FDA approval. The MIT study, which models the behavior of the balloons, should help scientists optimize their performance and aid regulators in evaluating their effectiveness and safety.
"Until now, people who evaluate such technology could not distinguish hype from promise," says Elazer Edelman, the Thomas D. and Virginia W. Cabot Professor of Health Sciences and Technology and senior author of the paper describing the study, which appeared online recently in the journal Circulation.
Lead author of the paper is Vijaya Kolachalama, a former MIT postdoc who is now a principal member of the technical staff at the Charles Stark Draper Laboratory.
Evolution of technology
Until the late 1970s, the standard treatment for patients with blocked arteries near the heart was bypass surgery. Doctors then turned to the much less invasive process of reopening arteries with angioplasty balloons. Angioplasty quickly became the standard treatment for narrowed arteries, but it is not always a long-term solution because the arteries can eventually collapse again.
To prevent that, scientists developed stents — metal, cage-like structures that can hold an artery open indefinitely. However, these stents have problems of their own: When implanted, they provoke an immune response that can cause cells to accumulate near the stent and clog the artery again.
In 2003, the FDA approved the first drug-eluting stent for use in the United States, which releases drugs that prevent cells from clumping in the arteries. Drug-eluting stents are now the primary choice for treating blocked arteries, but they also have side effects: The drugs can cause blood to clot over time, which has led to death in some patients. Patients who receive these stents now need to take other medications, such as aspirin and Plavix, to counteract blood clotting.
Edelman's lab is investigating a possible alternative to the current treatments: drug-coated balloons. "We're trying to understand how and when this therapy could work and identify the conditions in which it may not," Kolachalama says. "It has its merits; it has some disadvantages."
Modeling drug release
The drug-coated balloons are delivered by a catheter and inflated at the narrowed artery for about 30 seconds, sometimes longer. During that time, the balloon coating, containing a drug such as Zotarolimus, is released from the balloon. The properties of the coating allow the drug to be absorbed in the body's tissues. Once the drug is released, the balloon is removed.
In their new study, Kolachalama, Edelman and colleagues set out to rigorously characterize the properties of the drug-coated balloons. After performing experiments in tissue grown in the lab and in pigs, they developed a computer model that explains the dynamics of drug release and distribution. They found that factors such as the size of the balloon, the duration of delivery time, and the composition of the drug coating all influence how long the drug stays at the injury site and how effectively it clears the arteries.
One significant finding is that when the drug is released, some of it sticks to the lining of the blood vessels. Over time, that drug is slowly released back into the tissue, which explains why the drug's effects last much longer than the initial 30-second release period.
"This is the first time we can explain the reasons why drug-coated balloons can work," Kolachalama says. "The study also offers areas where people can consider thinking about optimizing drug transfer and delivery."
In future studies, Edelman, Kolachalama and colleagues plan to further examine how blood flow affects drug delivery. They also plan to study a variety of different drugs and drug coating compositions, as well as how the balloons behave in different types of arteries.
###
The National Institutes of Health and Abbott Vascular funded the research.
Written by Anne Trafton, MIT News Office
Evaluating a new way to open clogged arteries
Computational model offers insight into mechanisms of drug-coated balloons
2013-05-21
ELSE PRESS RELEASES FROM THIS DATE:
Mayo Clinic: How gold nanoparticles can help fight ovarian cancer
2013-05-21
ROCHESTER, Minn. — Positively charged gold nanoparticles are usually toxic to cells, but cancer cells somehow manage to avoid nanoparticle toxicity. Mayo Clinic researchers found out why, and determined how to make the nanoparticles effective against ovarian cancer cells. The discovery is detailed in the current online issue of the Journal of Biological Chemistry.
"This study identifies a novel mechanism that protects ovarian cancer cells by preventing the cell death or apoptosis which should occur when they encounter positively charged nanoparticles," say the senior authors ...
Rice unveils method for tailoring optical processors
2013-05-21
HOUSTON -- (May 21, 2013) -- Rice University scientists have unveiled a robust new method for arranging metal nanoparticles in geometric patterns that can act as optical processors that transform incoming light signals into output of a different color. The breakthrough by a team of theoretical and applied physicists and engineers at Rice's Laboratory for Nanophotonics (LANP) is described this week in the Proceedings of the National Academy of Sciences.
Rice's team used the method to create an optical device in which incoming light could be directly controlled with light ...
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery
2013-05-21
LOUISVILLE, Ky. – Grapefruits have long been known for their health benefits, and the subtropical fruit may revolutionize how medical therapies like anti-cancer drugs are delivered to specific tumor cells.
University of Louisville researchers have uncovered how to create nanoparticles using natural lipids derived from grapefruit, and have discovered how to use them as drug delivery vehicles. UofL scientists Huang-Ge Zhang, D.V.M., Ph.D., Qilong Wang, Ph.D., and their team today (May 21, 2013), published their findings in Nature Communications.
"These nanoparticles, ...
The pirate ant: A new species from the Philippines with a bizarre pigmentation pattern
2013-05-21
Scientists discovered a new enigmatic species of ant coming from the Philippines. Cardiocondyla pirata or the pirate ant engages the imagination with a bizarre pigmentation pattern that has no equivalent worldwide. The female castes in the colonies of these species can be recognized by a distinctive dark stripe across the eyes that resembles a pirate eye patch, which inspired the authors to choose the name of the species. The study was published in the open access journal Zookeys.
"On a collection trip to the Philippines we looked for different species of the genus ...
Waiting for a sign? Researchers find potential brain 'switch' for new behavior
2013-05-21
ANN ARBOR—You're standing near an airport luggage carousel and your bag emerges on the conveyor belt, prompting you to spring into action. How does your brain make the shift from passively waiting to taking action when your bag appears?
A new study from investigators at the University of Michigan and Eli Lilly may reveal the brain's "switch" for new behavior. They measured levels of a neurotransmitter called acetylcholine, which is involved in attention and memory, while rats monitored a screen for a signal. At the end of each trial, the rat had to indicate if a signal ...
JPIDS: Releases consensus statement on research definitions for drug-resistant TB in children
2013-05-21
ARLINGTON, VA, May 21, 2013—The Journal of the Pediatric Infectious Diseases Society (JPIDS) today released its June issue, which includes a consensus statement of the global Sentinel Project on Pediatric Drug-Resistant Tuberculosis. It establishes standardized definitions, measurements, and other key attributes that will effect research. This is the first step as the group of international stakeholders collaborate to raise visibility and share evidence and resources that can improve children's access to prompt and effective treatment.
Consensus Statement on Research ...
Single-cell transfection tool enables added control for biological studies
2013-05-21
Northwestern University researchers have developed a new method for delivering molecules into single, targeted cells through temporary holes in the cell surface. The technique could find applications in drug delivery, cell therapy, and related biological fields.
Bulk electroporation — a technique used to deliver molecules into cells through reversible nanopores in the cell membrane that are caused by exposing them to electric pulses — is an increasingly popular method of cell transfection. (Cell transfection is the introduction of molecules, such as nucleic acids or proteins, ...
Tiny, implantable coil promises hope for emphysema patients
2013-05-21
ATS 2013, PHILADELPHIA ─ A small, easily implantable device called the Lung Volume Reduction Coil (LVRC) may play a key role in the treatment of two types of emphysema, according to a study conducted in Europe. Results of the study indicate the beneficial effects of the device persist more than a year after initial treatment.
The study will be presented at the ATS 2013 International Conference.
"LVRC treatment results in significant and clinically relevant improvements in lung function, ability to exercise and quality of life for patients with emphysema," said ...
Exposure to traffic pollution increases asthma severity in pregnant women
2013-05-21
ATS 2013, PHILADELPHIA ─ Air pollutants from traffic are associated with increased asthma severity levels in pregnant asthmatic women, according to a new study.
"Air pollution is a known trigger for asthma symptoms," said lead author Janneane Gent, PhD, Research Scientist in Epidemiology (Environmental Health) at the Yale School of Public Health. "In our study, exposures were assessed using a sophisticated air pollution modeling system (Community Multiscale Air Quality, CMAQ) that permits community-level estimates (i.e., close to where the subject resides) instead ...
Study finds air pollution and noise pollution increase cardiovascular risk
2013-05-21
ATS 2013, PHILADELPHIA ─ Both fine-particle air pollution and noise pollution may increase a person's risk of developing cardiovascular disease, according to German researchers who have conducted a large population study, in which both factors were considered simultaneously.
"Many studies have looked at air pollution, while others have looked at noise pollution," said study leader Barbara Hoffmann, MD, MPH, a professor of environmental epidemiology at the IUF Leibniz Research Institute for Environmental Medicine in Germany. "This study looked at both at the same ...
LAST 30 PRESS RELEASES:
Thirty-year mystery of dissonance in the “ringing” of black holes explained
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative
Structure dictates effectiveness, safety in nanomedicine
[Press-News.org] Evaluating a new way to open clogged arteriesComputational model offers insight into mechanisms of drug-coated balloons